Search company, investor...
Dr. Martens company logo

Dr. Martens

Founded Year




Date of IPO


Market Cap


About Dr. Martens

Dr Martens is a global brand with a rich and diverse heritage and a contemporary relevance. Headquartered in Northants on the site of the original factory, it is sold in 63 countries, principally in the US, Asia, Europe and the UK. The company's deep-rooted links with the working class, music, subcultures and self-expression have kept the brand at the forefront of youth culture for over 50 years.

Headquarters Location

Cobbs Lane Wollaston

Northants, England, NN29 7SW,

United Kingdom

Missing: Dr. Martens's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Dr. Martens's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Dr. Martens News

BoF Insights | How to Prevent Supply Chain Headaches Turning Into a ‘Big Migraine’

Jan 25, 2023

Though pandemic-induced factory closures and port bottlenecks might be increasingly a distant memory for most fashion companies, it doesn’t necessarily mean supply chains have become more resilient to shocks. Last week, when Dr. Martens issued its second profit warning in two months, the British boot brand cited “ people and process issues ” impacting its supply chain, requiring it to lower expected full-year EBITDA to between £250 million and £260 million ($309 million and $321 million), around £16 million to £25 million less than previously stated. The company said fixing its supply chain could cost up to £11 million while up to £25 million of wholesale revenue could be lost. Shares in the company fell nearly one-third on the day of the announcement. As one analyst told Reuters, it’s “another big migraine” for Dr. Martens, following a profit warning late last year as strikes at a UK port and labour shortages at the bootmaker’s Dutch distribution centre weighed on earnings prospects. While perhaps an extreme case, Dr. Martens demonstrates how multiple pressures can hit a supply chain, with long-lasting and costly consequences. Though global supply chain snarls related to the Covid-19 pandemic have largely subsided, supply chain executives in the fashion industry surveyed by BoF Insights expect a range of pressures to persist into 2023 and beyond. Upstream factors are chief among future concerns, including the rising cost and availability of raw materials. At the same time, respondents have not shaken off the impact of the previous upstream challenges related to shipping and ports. A key for brands now will be to take a targeted approach to strengthening specific parts of their supply chains, be it around people — such as appointing a chief supply chain officer — or processes — by introducing greater digitisation to mitigate last mile delivery issues.

Dr. Martens Frequently Asked Questions (FAQ)

  • When was Dr. Martens founded?

    Dr. Martens was founded in 1992.

  • Where is Dr. Martens's headquarters?

    Dr. Martens's headquarters is located at Cobbs Lane, Northants.

  • What is Dr. Martens's latest funding round?

    Dr. Martens's latest funding round is IPO.

  • Who are the investors of Dr. Martens?

    Investors of Dr. Martens include Permira.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.